title: Antiphospholipid antibodies and malignancy.
abstract: Antiphospholipid antibody syndrome is characterized clinically by venous or arterial thrombosis, recurrent fetal loss, or placental insufficiency in women. This article describes the prevalence of malignancy, the manifestations, and the prognosis for this condition.
authors.affiliation: The University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Boulevard, Dallas, TX 75390-8852, USA.
authors.forename: Chi
authors.initials: C
authors.lastname: Pham
authors.forename: Yu-Min
authors.initials: YM
authors.lastname: Shen
mesh_terms: D017152:Antibodies, Antiphospholipid; D016736:Antiphospholipid Syndrome / Q000150:complications*; D006801:Humans; D009369:Neoplasms / Q000097:blood / Q000150:complications* / Q000276:immunology*; D012307:Risk Factors; D019851:Thrombophilia / Q000150:complications / Q000276:immunology; D013927:Thrombosis / Q000150:complications
chemical_list: D017152:Antibodies, Antiphospholipid